GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent AcquisitionNews DeskJune 9, 20260 GSK’s oncology strategy had focused on gynecological and blood cancers, but the pharmaceutical company is striking deals that broaden its…